Zhende Medical Co., Ltd. (SHA:603301)
China flag China · Delayed Price · Currency is CNY
82.00
-1.00 (-1.20%)
Nov 17, 2026, 3:00 PM CST

Zhende Medical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
837.93825.31596.161,0522,0751,358
Trading Asset Securities
221.14283.32232.23155.6299.675.22
Cash & Short-Term Investments
1,0591,109828.391,2072,1751,364
Cash Growth
-2.18%33.83%-31.39%-44.48%59.50%-41.00%
Accounts Receivable
819.9728.76764.06550.51793.96694.52
Other Receivables
55.7744.81148.6945.8634.0838.5
Receivables
875.67773.58912.74596.37828.04733.02
Inventory
901.58754.13770.72800.81929.59833.5
Other Current Assets
302.55222.71137.97115.22201.58265.55
Total Current Assets
3,1392,8592,6502,7204,1343,196
Property, Plant & Equipment
3,4253,5063,1582,8122,5282,178
Long-Term Investments
117.66118.46122.29195.07137.8184.83
Goodwill
1,0231,037788.78787.83474.49398.52
Other Intangible Assets
682.73722.68710.12607.1564.46444.82
Long-Term Deferred Tax Assets
64.7165.7165.2579.553.456.03
Long-Term Deferred Charges
29.420.0310.452.293.33.92
Other Long-Term Assets
16.1571.9371.9862.78-60.35
Total Assets
8,4988,4017,5777,2677,8966,422

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
488.54435.71399.62325.25646.77576.83
Accrued Expenses
120.65189.74231.63180.09320.84179.02
Short-Term Debt
997.15784.79300.19281.97165.55660.73
Current Portion of Long-Term Debt
7.9100.310.35110.1112.01-
Current Portion of Leases
-5.2335.443.129.75
Current Income Taxes Payable
51.6811.133.891059.0313.26
Current Unearned Revenue
26.4821.626.2144.88144.3947.84
Other Current Liabilities
151.14259.68165.15214.56167.02115.18
Total Current Liabilities
1,8441,8081,1601,1721,5191,603
Long-Term Debt
383.54383.1283.11200.17388.36145.16
Long-Term Leases
30.618.81.5239.2336.8132.73
Long-Term Unearned Revenue
215.21215.24218.02231.98176173.9
Long-Term Deferred Tax Liabilities
20.8323.3417.7818.6420.0527.68
Total Liabilities
2,4942,4391,6801,6622,1401,982

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
263.88265.84266.45266.45266.45227.2
Additional Paid-In Capital
1,6991,7721,7871,7871,782895.61
Retained Earnings
3,8573,6983,6023,3513,5523,009
Treasury Stock
--46.54-21.49-21.49-36.56-52.5
Comprehensive Income & Other
-76.02-3.148.95-17.71-23.61-12.42
Total Common Equity
5,7435,6875,6435,3665,5404,067
Minority Interest
261.03275.53253.15238.8215.32372.86
Shareholders' Equity
6,0045,9625,8965,6045,7564,440
Total Liabilities & Equity
8,4988,4017,5777,2677,8966,422

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,4191,282588.17636.92605.85848.36
Net Cash (Debt)
-360.13-173.59240.22570.51,569515.16
Net Cash Growth
---57.89%-63.64%204.55%-72.27%
Net Cash Per Share
-1.38-0.660.902.136.622.27
Filing Date Shares Outstanding
263.88251.76266.32266.32271.76225.1
Total Common Shares Outstanding
263.88251.76266.32266.32271.76225.1
Working Capital
1,2951,0511,4901,5482,6151,593
Book Value Per Share
21.7622.5921.1920.1520.3918.07
Tangible Book Value
4,0373,9274,1443,9714,5023,223
Tangible Book Value Per Share
15.3015.6015.5614.9116.5614.32
Land
-20.518.3921.991,386-
Buildings
-2,3431,8071,658-1,068
Machinery
-1,7801,6301,4531,1751,084
Construction In Progress
-468.59562.33388.39513.97514.07